Changes in the Immune Status in Adult Patients with Diabetes Mellitus in the Postcovid Period
Keywords:
Immune status, Diabetes Mellitus, Postcovid Period, CytokinesAbstract
Background: This study presents the results of an investigation into the immune status of adult patients with diabetes mellitus during the post-COVID period. Key cytokine levels, such as VEGF-A, TGF-β, IGF-1, and IP-10, as well as adhesion molecules VCAM-1 and ICAM-1, were analyzed. The study includes a comparison between vaccinated and unvaccinated patients, allowing for an assessment of the impact of vaccination on inflammatory processes and metabolic indicators.
Objective: To assess the effect of vaccination on immunological parameters in patients with diabetes that developed in the post-COVID period and identify key markers of inflammation and angiogenesis.
Materials and Methods: The study was conducted with 98 patients divided into three groups: vaccinated, unvaccinated patients with diabetes that developed after COVID-19, and a control group. Levels of VEGF-A, TGF-β, IGF-1, and IP-10 were measured using ELISA.
Results: The level of VEGF-A was higher in the group of unvaccinated patients (257.98±15.55 pg/ml), indicating more pronounced inflammatory processes compared to the vaccinated group. TGF-β and IGF-1 levels were also significantly elevated in the unvaccinated group, indicating the development of fibrotic changes in tissues.
References
Amin R, Bahadoram M, Sathyapalan T. The immunological role of adipokines in the metabolic syndrome. J Clin Endocrinol Metab. 2011;96(4):33-45.
Chen G, Wu D, Guo W, et al. Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. J Clin Invest. 2020;130(5):2620-2629.
Fernandez-de-Las-Penas C, Guijarro C, Torres-Macho J, et al. Diabetes and the risk of long-term post-COVID symptoms. Diabetes. 2021;70:2917-2921.
Fernández-Real JM, Pickup JC. Innate immunity, insulin resistance and type 2 diabetes. Diabetologia. 2012;55(10):273-283.
Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017-1032.
Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860-867.
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062.
